Latest Entitlement Offer News

360 Capital Mortgage REIT has reported a near doubling of its half-year profit to $2.6 million, driven by a 70% surge in investment income, alongside a successful $16.6 million capital raising. The Trust maintains a strong balance sheet with stable net asset value and a diversified loan portfolio.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Verity Resources is raising approximately $2 million through a non-renounceable entitlement offer to advance its Monument Gold and Botswana copper-silver projects, with directors backing the move through participation and underwriting.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Conico Ltd has finalised a major recapitalisation and corporate restructure, positioning itself for renewed exploration with a focus on scandium amid strong market demand. The company plans an extensive drilling program at its Mt Thirsty project to expand its scandium resource.

Altamin Limited progresses its Lazio geothermal lithium and SOP project with key technical studies and grant funding, while advancing a strategic sale process for its Gorno polymetallic project. The company bolsters its balance sheet through a successful entitlement offer raising A$5.39 million.

Redcastle Resources has reported exceptional high-grade gold assay results from its ongoing grade control drilling at Redcastle Reef, alongside key regulatory progress that paves the way for mining to commence mid-2026.

McLaren Minerals has completed a pivotal Pre-Feasibility Study for its McLaren Titanium Project, confirming a large-scale resource and robust economics, while also acquiring a zircon-rich asset to diversify its portfolio.